YUKA (Yuka Group) ROCE %: 10.41% (As of Sep. 2014)


What is Yuka Group ROCE %?

Yuka Group YUKA +7.33% ROCE % is 10.41% as of Sep. 2014.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Yuka Group's annualized ROCE % for the quarter that ended in Sep. 2014 was 10.41%.

Yuka Group  (OTCPK:YUKA) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Yuka Group ROCE % Related Terms

Yuka Group ROCE % Historical Data

* Premium members only.

The historical data trend for Yuka Group's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Yuka Group ROCE % Chart

Yuka Group Annual Data
Trend Dec09 Dec10 Dec11 Dec12 Dec13
ROCE %
0.00 0.00 0.00 0.00 -17,741.99

Yuka Group Quarterly Data
Dec09 Dec10 Mar11 Jun11 Sep11 Dec11 Sep12 Dec12 Mar13 Jun13 Dec13 Mar14 Jun14 Sep14
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6.93 0.00 26.90 24.74 10.41

Yuka Group ROCE % Calculation

Yuka Group's annualized ROCE % for the fiscal year that ended in Dec. 2013 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2013 )  (A: Dec. 2012 )(A: Dec. 2013 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2013 )  (A: Dec. 2012 )(A: Dec. 2013 )
=-55.355/( ( (0 - 0.033) + (1.716 - 1.059) )/ 2 )
=-55.355/( (-0.033+0.657)/ 2 )
=-55.355/0.312
=-17,741.99 %

Yuka Group's ROCE % of for the quarter that ended in Sep. 2014 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Sep. 2014 )  (Q: Jun. 2014 )(Q: Sep. 2014 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Sep. 2014 )  (Q: Jun. 2014 )(Q: Sep. 2014 )
=0.156/( ( (2.447 - 0.998) + (2.446 - 0.899) )/ 2 )
=0.156/( ( 1.449 + 1.547 )/ 2 )
=0.156/1.498
=10.41 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2014) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 10.41% mean?
Yuka Group (YUKA) has a ROCE % of 10.41% as of Sep. 2014.
Is Yuka Group's ROCE % too high?
Yuka Group's current ROCE % is 10.41%. The Retail - Cyclical industry median ROCE % is 7.59. Yuka Group's value of 10.41% is 37.2% above this industry median.
How does Yuka Group's ROCE % compare to ESTRF and HALN?
Yuka Group's ROCE % of 10.41% can be compared against companies in the Retail - Cyclical industry. The industry median ROCE % is 7.59. Yuka Group's value of 10.41% is 37.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Retail - Cyclical company?
The median ROCE % among Retail - Cyclical companies is 7.59, based on 1,112 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Yuka Group's current ROCE % of 10.41% is 37.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Retail - Cyclical industry, the median ROCE % is 7.59 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Yuka Group's current ROCE % is 10.41%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Yuka Group stock overvalued right now?
Yuka Group (YUKA) has a current ROCE % of 10.41%. The current ROCE % is 10.41% and 37.2% above the Retail - Cyclical industry median of 7.59. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Yuka Group (YUKA), the current ROCE % is 10.41% as of Sep. 2014. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Yuka Group Business Description

Address 20801 Biscayne Boulevard, Suite 403, Aventura, FL, USA, 33180
Yuka Group Inc is a holding company which operates through its subsidiary. It is a health care provider that provides products and services using edge specialized medical equipment, prescription medications, supplements, peptides, stem-cells, etc. to help patients with areas of their life that traditional medical doctors who are focused on sick care do not address. These areas include but are not limited to anti-aging medicine, esthetics, weight loss, increased energy, erectile dysfunction treatments, etc.